Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 89

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 16
Chunk 89
---
-term borrowings7,710 2,574 3,071 Repayments of long-term borrowings(1,650)(1,909)(1,899)Changes in securities lending payable16 (42)(36)Repurchase and retirement of common stock(2,900)(2,676)(2,316)Cash dividends(1,586)(1,466)(1,290)Proceeds from issuance of common stock under employee stock plans221 152 182 Taxes paid through withholding of common stock under employee stock plans(109)(99)(93)Other, net(717)153 217 Net cash provided by (used in) financing activities985 (3,313)(2,464)Change in cash and cash equivalents387 541 312 Cash and cash equivalents at beginning of year1,483 942 630 Cash and cash equivalents at end of year$1,870 $1,483 $942 See accompanying notes.

 -148-

Elevance Health, Inc.

(Parent Company Only)

Notes to Condensed Financial Statements

December 31, 2024 

(In Millions, Except Per Share Data)

1. Basis of Presentation and Significant Accounting PoliciesIn the parent company only financial statements of Elevance Health, Inc. (“Elevance Health”), Elevance Health’s investment in subsidiaries is stated at cost plus equity in undistributed earnings of the subsidiaries. Elevance Health’s share of net income of its unconsolidated subsidiaries is included in income using the equity method of accounting.Certain amounts presented in the parent company only financial statements are eliminated in the consolidated financial statements of Elevance Health.Elevance Health’s parent company only financial statements should be read in conjunction with Elevance Health’s audited consolidated financial statements and the accompanying notes included in Part II, Item 8 of this Annual Report on Form 10-K.

2. Subsidiary TransactionsDividends from SubsidiariesElevance Health received cash dividends from subsidiaries of $6,322, $4,909 and $3,097 during 2024, 2023 and 2022, respectively.Dividends to SubsidiariesCertain subsidiaries of Elevance Health own shares of Elevance Health common stock. Elevance Health paid cash dividends to subsidiaries related to these shares of common stock in the amount of $78, $71 and $61 during 2024, 2023 and 2022, respectively.Investments in SubsidiariesCapital contributions to subsidiaries